Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma.

BioMed research international - 1 Jan 2020

Wang Lidan, Zheng Kai, Li Xinlin, Wang Yang, Xu Qiong

Abstract excerpt

OBJECTIVE: The aim of this study is to evaluate the association of genetic polymorphisms in Cytochrome P450 2D6(CYP2D6) and the change in VEGF levels with the response to propranolol in patients with Infantile hemangiomas (IH). METHODS: IH patients who underwent over six months of propranolol therapy and received oral propranolol only were enrolled. The target dose of propranolol was 1 mg kg-1day-1....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemangioma

Share to Infant

Share to Polymorphism, Single Nucleotide

Share to Propranolol

Share to Treatment Outcome

Share to Vascular Endothelial Growth Factor A

Source

Open in PubMed Open full text

Identifiers

PMID: 32219146
DOI: 10.1155/2020/8732871
PMCID: PMC7081015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma.PMID 32219146Read ↗

Single-nucleotide polymorphisms of VEGF-A and VEGFR-2 genes and risk of infantile hemangioma.Semantic proximity Read ↗

Practice variations in managing infantile hemangiomasSemantic proximity Read ↗

Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro.Semantic proximity Read ↗

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro ValidationSemantic proximity Read ↗

Timolol reports for infantile hemangioma contain systemic beta- blocker signals in FAERS/openFDASemantic proximity Read ↗

Circular RNA hsa_circ_0000915 promotes propranolol resistance of hemangioma stem cells in infantile haemangiomasSemantic proximity Read ↗

Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangiomaSemantic proximity Read ↗

Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β‐Adrenergic SystemSemantic proximity Read ↗

Current knowledge of the pathogenesis of infantile hemangiomas.Semantic proximity Read ↗

Influence of genetic variants on the pharmacokinetics and pharmacodynamics of sirolimus: a systematic review.Semantic proximity Read ↗

Influence of CYP2D6 genetic variation on adverse events with propafenone in the pediatric and young adult population.Semantic proximity Read ↗

[The expression and role of glucose transporter-1 in infantile hemangioma].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.